ArticleTranslational lung cancer research2018

Repurposing established cyclic adenosine monophosphate reducing agents for the prevention and therapy of epidermal growth factor receptor inhibitor resistance in non-small cell lung cancer.

Hildegard M SchullerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.